HK160795A - Bilobalide phospholipide complexes their applications and formulations containing them - Google Patents

Bilobalide phospholipide complexes their applications and formulations containing them

Info

Publication number
HK160795A
HK160795A HK160795A HK160795A HK160795A HK 160795 A HK160795 A HK 160795A HK 160795 A HK160795 A HK 160795A HK 160795 A HK160795 A HK 160795A HK 160795 A HK160795 A HK 160795A
Authority
HK
Hong Kong
Prior art keywords
bilobalide
complexes
phospholipide
applications
inflammatory
Prior art date
Application number
HK160795A
Other languages
English (en)
Inventor
Ezio Bombardelli
Giuseppe Mustich
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of HK160795A publication Critical patent/HK160795A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • C07F9/106Adducts, complexes, salts of phosphatides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK160795A 1990-02-09 1995-10-12 Bilobalide phospholipide complexes their applications and formulations containing them HK160795A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19324A IT1238684B (it) 1990-02-09 1990-02-09 Derivati del bilobalide,loro usi e formulazioni che li contegono

Publications (1)

Publication Number Publication Date
HK160795A true HK160795A (en) 1995-10-20

Family

ID=11156741

Family Applications (1)

Application Number Title Priority Date Filing Date
HK160795A HK160795A (en) 1990-02-09 1995-10-12 Bilobalide phospholipide complexes their applications and formulations containing them

Country Status (11)

Country Link
US (1) US5202313A (it)
EP (1) EP0441279B1 (it)
JP (1) JP3036881B2 (it)
KR (1) KR0170773B1 (it)
AT (1) ATE115585T1 (it)
CA (1) CA2035951C (it)
DE (1) DE69105767T2 (it)
DK (1) DK0441279T3 (it)
ES (1) ES2066239T3 (it)
HK (1) HK160795A (it)
IT (1) IT1238684B (it)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
DE540767T1 (de) * 1991-11-04 2001-10-25 Ruth-Maria Korth Behandlung und Vorbeugung von von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten
DE540766T1 (de) * 1991-11-04 2002-11-28 Ruth-Maria Korth Behandlung von Eosinophil-mediierten Erkrankungen mit PAF-Antagonisten, und Verfahren zur Bestimmung deren Effektivität.
GB9202993D0 (en) * 1992-02-13 1992-03-25 Indena Spa Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
GB9205670D0 (en) * 1992-03-16 1992-04-29 Indena Spa New derivatives of physostigmine,their use and pharmaceutical formulations containing them
US5456912A (en) * 1993-12-28 1995-10-10 The Regents Of The University Of California Non-methylene interrupted fatty acids as immunomodulators
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
WO1999064028A1 (en) * 1998-06-11 1999-12-16 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Protecting neurons from ischemia
US7494643B2 (en) * 2003-07-22 2009-02-24 Rendon Marta I Method and topical composition for the treatment of hyperpigmented skin
ES2323864T3 (es) 2004-01-29 2009-07-27 Indena Spa Uso de complejos de ginkgo para la potenciacion de las funciones cognitivas y alivio de la fatiga mental.
ITMI20060136A1 (it) * 2006-01-27 2007-07-28 Pharmextracta S R L Composizioni a base di derivati della ginkgo biloba per il trattamento di condizioni asmatiche e allergiche
ITMI20071492A1 (it) 2007-07-24 2009-01-25 S I I T Srl Servizio Internazi "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba"
IT1397386B1 (it) 2010-01-12 2013-01-10 Indena Spa Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso.
IT1402672B1 (it) 2010-11-08 2013-09-13 Medestea Biotech S P A Composizioni comprendenti principi attivi di origine vegetale associati o meno a promotori e/o protettori di ossido nitrico per il trattamento e la prevenzione dei deficit erettili e dell' impotenza e per il potenziamento della performance sportiva
ITTO20110901A1 (it) 2011-10-10 2013-04-11 Medestea Biotech S P A Composizione sinergica per la prevenzione ed il trattamento di disturbi connessi all'invecchiamento
CN109851634B (zh) * 2018-12-25 2020-12-22 华东师范大学 手性单膦配体Yu-Phos及其全构型的制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
DD213672A1 (de) * 1983-03-04 1984-09-19 Akad Wissenschaften Ddr Verfahren zur herstellung von gibberellin-derivaten mit 13,16-anneliertem oxathiaphospholan-ring
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
JPH0231646A (ja) * 1988-07-21 1990-02-01 Daicel Chem Ind Ltd イチョウ抽出物入りチョコレート
JPH0231648A (ja) * 1988-07-21 1990-02-01 Daicel Chem Ind Ltd イチョウ抽出物入りチューインガム

Also Published As

Publication number Publication date
JPH06145174A (ja) 1994-05-24
IT9019324A0 (it) 1990-02-09
KR910015308A (ko) 1991-09-30
CA2035951A1 (en) 1991-08-10
JP3036881B2 (ja) 2000-04-24
US5202313A (en) 1993-04-13
ATE115585T1 (de) 1994-12-15
IT9019324A1 (it) 1991-08-09
ES2066239T3 (es) 1995-03-01
CA2035951C (en) 2001-07-31
EP0441279B1 (en) 1994-12-14
EP0441279A1 (en) 1991-08-14
DE69105767T2 (de) 1995-04-27
IT1238684B (it) 1993-09-01
DE69105767D1 (de) 1995-01-26
KR0170773B1 (ko) 1999-03-30
DK0441279T3 (da) 1995-05-08

Similar Documents

Publication Publication Date Title
HK160795A (en) Bilobalide phospholipide complexes their applications and formulations containing them
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
IT1150608B (it) Complessi platino-diamminici e procedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi
IL94267A0 (en) Compositions for treating skin disorders containing ketoconazole and their preparation
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ATE121949T1 (de) 5,10-methylentetrahydrofolsäure-cyclodextrin- einschlussverbindungen.
EP0299424A3 (en) Thiosulfinic-acid derivatives, their use in the treatment of inflammatory diseases, and medicaments containing these substances
GB9205670D0 (en) New derivatives of physostigmine,their use and pharmaceutical formulations containing them
ZA905932B (en) 14,17alpha-etheno-and-ethanoestratrienes,processes for the preparation of these compounds,as well as their use for the production of medicinal agents
IT1237509B (it) Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ZA898274B (en) 2-aminocarboxylic acids and their derivatives,processes for their preparation and their use as medicaments
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
IT8848258A0 (it) Composizione farmaceutica per il trattamento delle affezioni parodontali
ITMI912027A0 (it) Derivati dell'eserolina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911842A0 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911841A0 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911713A0 (it) Derivati dell'eseridina utili per il trattamento delle malattie associate a disordini colinergici, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090207